Pharma's strategy − The naming game (Part I; see the December 13, 2011 LRTJ analyst insight) brought our attention to Pfizer's last ditch attempt to hold onto Lipitor. Despite desperately dishing...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)